1. Market Research
  2. > Healthcare Market Trends
  3. > South Korea: Clinical Development Country Profile

South Korea: Clinical Development Country Profile

  • June 2013
  • -
  • Industry Standard Research
  • -
  • 109 pages

In this report, ISR provides insight into the clinical development environment, sponsor and service provider activities, and population “health status” for South Korea.

Valuable for:

• Clinical Operations
• Medical Directors
• C-Suite
• Portfolio Management

How you can use this report:

• Understand how sponsors and CROs view South Korea as a site for clinical trials
• Uncover logistical details for conducting South Korean trials
• Illustrate the benefits and drawbacks of conducting trials in South Korea
• Learn how South Korea compares to other countries on a variety of scales so the reader can best consider the areas in which South Korea may be beneficial as a trial site for their particular company

What you will learn in this report:

• How population characteristics, qualified investigators, and government policies and incentives make South Korea the 8th most active and most valuable country for clinical trial activity
• On-the-ground insights from numerous high-level R&D employees in sponsor organizations and country heads from multinational CROs
• Health statistics in Korea, including disease incidence and prevalence, use of imaging technologies, and use of medicines in major therapy areas
• Contact details for pharma companies and principal investigators in South Korea

Table Of Contents

South Korea: Clinical Development Country Profile
Table of Contents

Copyright and Usage Guidelines 5
Methodology 6
Introduction 8
South Korea Background 12
Population 12
Health Care Expenditures 12
Therapeutic Areas 12
Market Landscape 12
Insurance and Reimbursement 14
Korean Investigator Capabilities 14
Industry Interviews 15
Sponsor Interviews 15
Global Head of Clinical Operations at Top 5 European Pharma Company 15
Vice President and Head of Clinical Development at Top 50 Pharma Company 17
CRO Interviews 18
Quintiles 18
ICON 20
INC Research 21
Korea Health Statistics 23
Health Status Summary 23
Causes of death 24
Cancer incidence 25
Female breast cancer incidence 26
Male prostate cancer incidence 27
Diabetes prevalence 28
AIDS and HIV incidence and prevalence 29
Tuberculosis incidence and prevalence 30
Dementia prevalence 31
Health Care Technology and Medication Use 32
CT scanners 32
CT exams 33
MRI units 34
MRI exams 35
Antibiotic consumption 36
Anti-cholesterols consumption 37
Antidepressants consumption 38
Anti-diabetics consumption 39
Anti-diabetics consumption 40
Health Expenditure and Financing 40
Expenditure on pharmaceuticals per capita 40
Out-of-pocket expenditure 41
Growth in real per capita pharmaceutical expenditures 42
Service Provider Capabilities 43
Domestic Clinical Service Providers 44
Applied Biopharm Inc. 44
Background / History 44
Services Offered 45
CandR Research 46
Background / History 46
Master Agreement and Preferred Vendor 47
Corporate Structure 47
Services Offered 48
Therapeutic Areas 49
Press Releases 49
DreamCIS Inc. 50
Background / History 50
Master Agreement and Preferred Vendor 50
Corporate Structure 51
Services Offered 52
Therapeutic Areas 53
Press Releases 54
GDFI Co., Ltd. 55
Background / History 55
Corporate Structure 56
Services Offered 57
LSK Global PS 58
Background / History 58
Master Agreement and Preferred Vendor 58
Corporate Structure 59
Services Offered 60
Therapeutic Areas 61
Press Releases 62
Medical Excellence Inc. (MediCROStar) 63
Background/History 63
Corporate Structure 63
Services offered 64
Therapeutic Areas 65
Press releases 66
Orient Bio 68
Background / History 68
Services Offered 69
Financials 70
Press Releases 71
PharmaCRO 72
Background / History 72
Services Offered 73
Therapeutic Areas 73
Domestic Non-Clinical Service Providers 74
Bio-Core Co., Ltd. 74
Background / History 74
Corporate Structure 74
Services Offered 75
Press Releases 76
Biotoxtech 77
Background / History 77
GLP Certification 78
Corporate Structure 79
Services Offered 80
Financials 81
Chemon Inc. 82
Background / History 82
GLP Certification 82
Services Offered 83
Press Releases 84
Korean Institute of Toxicology (KIT) 85
Background / History 85
GLP Certification 85
Services Offered 86
Domestic Service Provider Contact Summary 88
International CRO List and Contact Details 89
Domestic Pharma Company List and RandD Expenditure 90
International Pharma Company List and Locations 92
Clinical Investigator List and Contact Details 93
About ISR 109




Companies Mentioned

Applied Biopharm Inc.
CandR Research
DreamCIS Inc.
GDFI Co., Ltd.
LSK Global PS
Medical Excellence Inc. (MediCROStar) Orient Bio
PharmaCRO
BIO-Core Co., Ltd.
Biotoxtech
Chemon Inc.
Korean Institute of Toxicology (KIT)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.